When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Fibrose cística

Última revisión: 13 Jan 2026
Última actualización: 10 Oct 2025

Resumen

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • rastreamento neonatal positivo
  • ausência de eliminação de mecônio
  • retardo do crescimento pôndero-estatural
  • apetite voraz
  • tosse produtiva
  • infecção recorrente
  • rinossinusite crônica
  • anormalidades genitais masculinas
  • hemoptise
Detalhes completos

Outros fatores diagnósticos

  • fezes disabsortivas com esteatorreia
  • baqueteamento digital
  • refluxo gastroesofágico
  • sibilo
  • diâmetro anteroposterior (AP) aumentado do tórax
  • história de pancreatite
  • história de apendicite aguda
  • hepatomegalia ou esplenomegalia
Detalhes completos

Fatores de risco

  • história familiar de fibrose cística (FC)
  • status de portador conhecido de ambos os pais
  • etnia
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • teste do suor
  • teste genético
Detalhes completos

Investigações a serem consideradas

  • exames de imagem do seio nasal
  • swab de orofaringe posterior
Detalhes completos

Algoritmo de tratamento

AGUDA

neonatos com íleo meconial/obstrução intestinal distal parcial

obstrução intestinal completa ou peritonite

infecção respiratória aguda

CONTÍNUA

doença respiratória

doença gastrointestinal

Colaboradores

Autores

Samuel B. Goldfarb, MD

Professor of Pediatrics

Masonic Children's Hospital

University of Minnesota School of Medicine

Minneapolis

MN

Declarações

SBG declares a personal interest in the Cystic Fibrosis Therapeutic Development Network (TDN) involving multiple CF multicentred studies.

Pi Chun (Jennifer) Cheng, MD, MS

Assistant Professor of Pediatrics

Riley Hospital for Children

Indiana University School of Medicine

Indianapolis

IN

Declarações

PCC declares that she has no competing interests.

Maureen Banfe Josephson, DO

Assistant Professor of Pediatrics

The Children's Hospital of Philadelphia

Perelman School of Medicine at the University of Pennsylvania

Philadelphia

PA

Declarações

MBJ declares that she has no competing interests.

Agradecimentos

Dr Samuel B. Goldfarb, Dr Pi Chun (Jennifer) Cheng, and Dr Maureen Banfe Josephson would like to gratefully acknowledge Dr James L. Kreindler, a previous contributor to this topic.

Declarações

JLK declares that he has no competing interests.

Revisores

Sangeeta M. Bhorade, MD

Associate Professor of Medicine

Medical Director

Lung Transplant Program

University of Chicago Hospitals

Chicago

IL

Divulgaciones

SMB declares that she has no competing interests.

Alan Smyth, MA, MBBS, MRCP, MD, FRCPCH

Associate Professor & Reader in Child Health

Division of Child Health

University of Nottingham

Queens Medical Centre

Nottingham

UK

Divulgaciones

AS declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Farrell PM, White TB, Ren CL, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017 Feb;181S:S4-15.e1.Texto completo  Resumen

Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013 Apr 1;187(7):680-9.Texto completo  Resumen

Flume PA, Robinson KA, O'Sullivan BP, et al; Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009 Apr;54(4):522-37.Texto completo  Resumen

Ramos KJ, Smith PJ, McKone EF, et al. Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines. J Cyst Fibros. 2019 May;18(3):321-33.Texto completo  Resumen

Kapnadak SG, Dimango E, Hadjiliadis D, et al. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros. 2020 May;19(3):344-54.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Fibrose cística images
  • Differentials

    • Discinesia ciliar primária
    • Imunodeficiência primária
    • Asma
    Más Diferenciales
  • Guidelines

    • Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
    • Models of palliative care delivery for individuals with cystic fibrosis
    Más Guidelines
  • Patient information

    Fibrose cística: o que é?

    Fibrose cística: quais são as opções de tratamento?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer